SCHEMBL30107035

SCHEMBL30107035

NC(=O)c1cc(NC(=O)c2c(C(F)(F)F)c(C(F)F)nn2CC2CCC(F)(F)CC2)ccc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.38
AKR1C2 P52895 1/20 0.38
BACE1 P56817 7/20 0.34
BACE2 Q9Y5Z0 3/20 0.34
ENPP2 Q13822 1/20 0.34
NR3C1 P04150 3/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
SLC6A4 P31645 1/20 0.33
KDM1A O60341 1/20 0.33
SCN10A Q9Y5Y9 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
EPHX2 P34913 1/20 0.31
P2RX3 P56373 1/20 0.31
P2RX7 Q99572 1/20 0.31
SYK P43405 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24906485 1.00 AKR1C3 (0.38) AKR1C3AKR1C2BACE1BACE2ENPP2
SCHEMBL24758397 0.92 AKR1C3 (0.35) AKR1C3AKR1C2BACE1BACE2CYP1A2
SCHEMBL30107007 0.89 AKR1C3 (0.39) AKR1C3AKR1C2BACE1BACE2NR3C1
SCHEMBL30106989 0.89 NR3C1 (0.40) AKR1C3AKR1C2BACE1BACE2NR3C1
SCHEMBL24758208 0.89 AKR1C3 (0.39) AKR1C3AKR1C2BACE1BACE2NR3C1
SCHEMBL24757816 0.89 NR3C1 (0.40) AKR1C3AKR1C2BACE1BACE2NR3C1
SCHEMBL30107015 0.89 HTR2A (0.35) AKR1C3AKR1C2BACE1NR3C1HTR2A
SCHEMBL24906534 0.89 HTR2A (0.35) AKR1C3AKR1C2BACE1NR3C1HTR2A
SCHEMBL24906423 0.86 SCN10A (0.44) AKR1C3AKR1C2SCN10A
SCHEMBL24758290 0.84 NR3C1 (0.38) AKR1C3AKR1C2BACE1BACE2NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11999699-B2 Substituted pyrazole amides Grünenthal GmbH (DE) 2024-06-04 US disclosed
US-20230025025-A1 SUBSTITUTED PYRAZOLE AMIDES GRUENENTHAL GMBH (DE) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11999699-B2 Substituted pyrazole amides SCN8A, SCN1A, SCN7A AKR1C3 1950/4885AKR1C2 1995/4885BACE1 2182/4885
US-20230025025-A1 SUBSTITUTED PYRAZOLE AMIDES SCN8A, SCN1A, SCN7A AKR1C3 1950/4885AKR1C2 1995/4885BACE1 2182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.